Many MM driver mutations occur in known cancer-signaling pathways, such as the Rat sarcoma virus (RAS), mitogen-activated protein kinase (MAPK), and PI3K/AKT pathways, which are known to control proliferation and survival of MM cells (2, 3). Here, AKT1 is linked to Miyoshi myopathy.